Delivery Order SPE2DB22D2214-SPE2DB25FS5PV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,670.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5 milliliter pens of Mounjaro 2.5 milligrams, a diabetes medication. The contract was competitively awarded with no set-aside designation and is scheduled for completion by September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,635.27 for Mounjaro 5 mg/0.5 mL pen (0.5 mL), a diabetes medication, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,162.70 by the Defense Logistics Agency on September 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by September 19, 2025, with the place of performance located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,131.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.72 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a prescription diabetes medication. The contract was awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, and utilizes firm fixed price pricing. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $12,526.15 delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens, a diabetes treatment medication. This firm fixed-price delivery order, with a completion date of June 30, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was not set-aside and was competitively awarded, demonstrating AmerisourceBergen's capability to meet federal procurement requirements...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on May 8, 2025, for Mounjaro 15 mg/0.5 ml pen (a diabetes medication), with a contract ceiling value of $1,108.24 and firm fixed pricing. This competitive award, with no set-aside designation, is performed at the contractor's location in Conshohocken, Pennsylvania, and is scheduled for completion by May 9, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5PVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,722.65 firm fixed price delivery order for Mounjaro 5 mg/0.5 mL pens on June 30, 2025, with completion scheduled for July 1, 2025. This non-set-aside contract represents a single delivery of the diabetes medication to support federal healthcare needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving military and federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability in competitively awarded pharmaceutical procurement across multiple therapeutic domains, positioning it as a critical vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 6/30/25 |